Arvinas, Inc. vs Johnson & Johnson — Stock Comparison

ARVN
Arvinas, Inc.
$10.51
▲ 6.16%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 5/10

Q·Score Breakdown

5
Bearish
Overall
7.1
Bullish
0.8
Quality
9.3
9.2
Health
6.5
4.3
Growth
5.1
6.3
Valuation
7.3
5.9
Sentiment
6.5
ARVN

Clean balance sheet with low leverage (0.0× debt-to-equity).

currently unprofitable (-31% margin).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

HOLD
Target $14.88 (+41.5%)
16 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

ARVN
JNJ
Trailing P/E
26.3×
-3.0×
Forward P/E
17.9×
-30.8%
Profit Margin
21.8%
100.0%
Gross Margin
68.0%
-16.2%
ROE
26.4%
-84.0%
Revenue Growth
9.9%
Earnings Growth
-52.9%
1.98
Beta
0.33
Price / Book
$672M
Market Cap
$546.9B
$6 – $15
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →